Detalhe da pesquisa
1.
Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Clin Infect Dis
; 65(7): 1174-1182, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29126292
2.
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults.
J Infect Dis
; 208(9): 1375-85, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23908479
3.
A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR).
Hum Vaccin Immunother
; 20(1): 2321035, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497448
4.
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).
Hum Vaccin Immunother
; 18(1): 1-14, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726574
5.
Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older.
Hum Vaccin Immunother
; 17(8): 2678-2690, 2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019468
6.
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
Hum Vaccin Immunother
; 15(3): 540-548, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427749
7.
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults.
Hum Vaccin Immunother
; 15(3): 530-539, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30648919
8.
Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects.
Hum Vaccin Immunother
; 12(8): 2142-2147, 2016 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27149114
9.
Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes.
Hum Vaccin Immunother
; 12(8): 2135-2141, 2016 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27002793